Blueberry Therapeutics secures additional GBP3.6m Series B investment
Drug discovery and development company, Blueberry Therapeutics, has secured a GBP3.6 million extension to its previously successful GBP10.8 million Series B fundraising. Japanese investor, Medical Incubator Japan (MIJ), and a private syndicate of US Board Certified Dermatologists – led by Dr Omar Ibrahimi of the Connecticut Skin Institute – have